IgA Nephropathy/Henoch–Schönlein Purpura
General Principles
- IgA nephropathy is a result of abnormal glycosylation of the hinge region of immunoglobulin A. This results in autoantibodies which interact with abnormally glycosylated protein and cause glomerular disease. Although serum IgA levels do not correlate with disease activity, events that potentially lead to overproduction (concurrent upper respiratory infection) or decreased clearance (hepatic cirrhosis) may predispose to development of this disease.
- This disease process is typically idiopathic, characterized by a nephritic picture with microscopic (and less commonly, macroscopic) hematuria and nonnephrotic range proteinuria.
- Presentation is usually in the second or third decade of life, often following a slowly progressive course. Multiple forms of pathology exist, from mild lesions and mesangial proliferation to global sclerosis resulting in progression to ESRD.
- Henoch–Schönlein purpura is a related disorder that may represent a systemic form of the disease, with vasculitis of the skin (palpable purpura of the lower trunk and extremities), gastrointestinal tract, and joints.
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Bhat, Pavat, et al., editors. "IgA Nephropathy/Henoch–Schönlein Purpura." Washington Manual of Medical Therapeutics, 35th ed., Wolters Kluwer Health, 2016. The Washington Manual, www.unboundmedicine.com/washingtonmanual/view/Washington-Manual-of-Medical-Therapeutics/602815/all/IgA_Nephropathy_Henoch–Schönlein_Purpura.
IgA Nephropathy/Henoch–Schönlein Purpura. In: Bhat PP, Dretler AA, Gdowski MM, et al, eds. Washington Manual of Medical Therapeutics. Wolters Kluwer Health; 2016. https://www.unboundmedicine.com/washingtonmanual/view/Washington-Manual-of-Medical-Therapeutics/602815/all/IgA_Nephropathy_Henoch–Schönlein_Purpura. Accessed June 5, 2023.
IgA Nephropathy/Henoch–Schönlein Purpura. (2016). In Bhat, P., Dretler, A., Gdowski, M., Ramgopal, R., & Williams, D. (Eds.), Washington Manual of Medical Therapeutics (35th ed.). Wolters Kluwer Health. https://www.unboundmedicine.com/washingtonmanual/view/Washington-Manual-of-Medical-Therapeutics/602815/all/IgA_Nephropathy_Henoch–Schönlein_Purpura
IgA Nephropathy/Henoch–Schönlein Purpura [Internet]. In: Bhat PP, Dretler AA, Gdowski MM, Ramgopal RR, Williams DD, editors. Washington Manual of Medical Therapeutics. Wolters Kluwer Health; 2016. [cited 2023 June 05]. Available from: https://www.unboundmedicine.com/washingtonmanual/view/Washington-Manual-of-Medical-Therapeutics/602815/all/IgA_Nephropathy_Henoch–Schönlein_Purpura.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - IgA Nephropathy/Henoch–Schönlein Purpura
ID - 602815
ED - Williams,Dominique,
ED - Bhat,Pavat,
ED - Dretler,Alexandra,
ED - Gdowski,Mark,
ED - Ramgopal,Rajeev,
BT - Washington Manual of Medical Therapeutics
UR - https://www.unboundmedicine.com/washingtonmanual/view/Washington-Manual-of-Medical-Therapeutics/602815/all/IgA_Nephropathy_Henoch–Schönlein_Purpura
PB - Wolters Kluwer Health
ET - 35
DB - The Washington Manual
DP - Unbound Medicine
ER -